Cleveland Clinic’s Nissen Asks HELP Panel For Stronger Supplement Regulation
This article was originally published in The Tan Sheet
Executive Summary
Pending legislation on adverse event reporting does not go far enough in expanding regulatory oversight of dietary supplements, the American College of Cardiology president told a Senate committee Nov. 16